Nucleic Acid Amplification Detection and Diagnostics Market to Create New Opportunities Till 2027
Nucleic acid amplification technologies are used for the rapid and
accurate diagnosis of chronic and infectious diseases. The nucleic acid
amplification is one of the important tool for wide aspects of life science
technologies including, clinical medicine development, diagnosis of infectious
diseases, and gene cloning. Extensively increasing prevalence of chronic as
well as infectious diseases is boosting the demand for state-of-the-art
diagnostic systems. The nucleic
acid amplification, detection, and diagnostics market is expected to
witness a significant growth due to increasing prevalence of infectious
diseases and rising demand for advanced diagnostic systems. However, lack of
adequate infrastructure in emerging countries is estimated to hamper the growth
of the market during the forecast period.
The growth of the nucleic acid amplification, detection, and
diagnostics market is attributed to the factors such as increasing prevalence
of chronic conditions and increasing demand for accurate and modern diagnostic
measures. However, lack of expertise and inadequate infrastructure in emerging
countries is likely to restraint the growth of the market during the forecast
period.
Sample PDF showcases the content structure and
the nature of the information included in the report which presents a
qualitative and quantitative analysis – https://www.theinsightpartners.com/sample/TIPRE00016305/
Leading Nucleic Acid Amplification Detection and Diagnostics
Market Players:
- BD
- bioMerieux
SA
- BIO-RAD
LABORATORIES INC.
- THERMO
FISHER SCIENTIFIC INC.
- Illumina,
Inc.
- Danaher
- QIAGEN
- Abbott
- Meridian
Bioscience, Inc.
- F.
Hoffmann-La Roche Ltd.
The report segments Global Nucleic Acid
Amplification, Detection, and Diagnostics Market as follows:
By Nucleic Acid
·
Deoxyribonucleic Acid
(DNA)
·
Ribonucleic Acid (RNA)
By Process
·
Diagnostics
·
Amplification
o Transcription-Mediated Amplification
(TMA)
o Loop-Mediated Isothermal Amplification
(LMIA)
o Strand Displacement Amplification
(SDA)
o Helicase-Dependent Amplification (HDA)
o Nucleic Acid Sequence-Based
Amplification (NASBA)
o Others
·
Detection
By Product Type
·
Kits and Reagents
·
Assays
·
Systems
By Technology
·
Polymerase Chain Reaction
(PCR)
o Quantitative PCR (qPCR)
o Reverse-Transcriptase (RT–PCR)
o Multiplex PCR
o Nested PCR
o In-situ PCR
o Others
Nucleic Acid-Based Insights
Based
on nucleic acid, the nucleic acid amplification, detection, and diagnostics
market is segmented into deoxyribonucleic acid (DNA) and ribonucleic acid
(RNA). In 2019, the deoxyribonucleic acid (DNA) segment held the largest share
of the market; also, the same segment is likely to witness the fastest growth
during the forecast period.
Process-Based Insights
Based
on process, the nucleic acid amplification, detection, and diagnostics market
is segmented into diagnostics, amplification, and detection. The amplification
segment is further sub-segmented as transcription-mediated amplification (TMA),
loop-mediated isothermal amplification (LMIA), strand displacement
amplification (SDA), helicase-dependent amplification (HDA), nucleic acid
sequence-based amplification (NASBA), and others. The diagnostics segment held
the largest share of the market in 2019 and is estimated to register the
fastest growth during the forecast period.
Product
Type-Based Insights
Based
on product type, the nucleic acid amplification, detection, and diagnostics
market is segmented into kits & reagents, assays, and systems. The kits
& reagents segment held the largest share of the market in 2019 and is
estimated to register the fastest growth during the forecast period.
Technology-Based
Insights
Based
on technology, the nucleic acid amplification, detection, and diagnostics
market is segmented into polymerase chain reaction (PCR), next generation
sequencing (NGS), isothermal amplification technology, direct nucleic acid
detection, and CRISPR-Cas9. The polymerase chain reaction (PCR) segment is
further sub-segmented as Quantitative PCR (qPCR), reverse-transcriptase
(RT–PCR), multiplex PCR, nested PCR, in-situ PCR, and others. In addition,
isothermal amplification technology segment is sub-segmented as target
amplification systems, probe amplification systems, and signal amplification
systems. Direct nucleic acid detection segment is further sub-segmented as
aptamers, DNA biosensors, and others. The polymerase chain reaction (PCR)
segment held the largest share of the market in 2019 and is estimated to
register the fastest growth during the forecast period.
Application-Based
Insights
Based
on application, the nucleic acid amplification, detection, and diagnostics
market is segmented into infectious diseases, genetic diseases, oncology,
forensic testing, paternity testing, and others. The infectious diseases
segment held the largest share of the market in 2019; whereas, oncology segment
is estimated to register the fastest growth during the forecast period.
Immediate delivery of our off-the-shelf reports and pre booking
of upcoming studies, through flexible and convenient payment methods – https://www.theinsightpartners.com/buy/TIPRE00016305/
Nucleic Acid Amplification Detection and Diagnostics Market
Segmented by Region/Country: North America, Europe, Asia Pacific, Middle East
& Africa, and Central & South America
About Us:
The Insight Partners is a one stop industry research
provider of actionable intelligence. We help our clients in getting solutions
to their research requirements through our syndicated and consulting research
services. We specialize in industries such as Semiconductor and Electronics,
Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare
IT, Manufacturing and Construction, Medical Device, Technology, Media and
Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you
would like further information, please
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Comments
Post a Comment